Based on this review, there is prior knowledge and data supporting considerations for dietary supplementation with GLP-1RA treatment
Let's take a closer look at the sequence of events and what is required to produce GLP-1
I feel incredibly fortunate to have joined the MDWatch program and to have been paired with my nurse practitioner, Kristi Richards
Kynurenine is subsequently converted to NAD + in a chain of reactions with the rate-limiting step by quinolinic phosphoribosyltransferase (QPRT), which converts quinolinic acid into nicotinic acid mononucleotide (NAMN) 26 , finally entering the PreissHandler pathway
Currently the most serious vision risk from GLP-1 usage is NAION, which can cause total blindness
[1] [2] If considering changing your weekly injection day, the SmPC specifies that at least 3 days must elapse between doses